Pasqua MR, Jafar A, Kobayati A, Tsoukas MA, et al. Low-Dose Empagliflozin as Adjunct to Hybrid Closed-Loop Insulin Therapy in Adults With Suboptimally Controlled Type 1 Diabetes: A Randomized Crossover Controlled Trial. Diabetes Care 2022 Nov 4. pii: 147853. doi: 10.2337/dc22-0490.
PMID: 36331522